Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma.
Standard automated perimetry (SAP) is today still the clinical standard for the management of glaucoma and its progression, though it has been shown that it may detect the disease only after the death of a high number of retinal ganglion cells (RGCs). A number of "unconventional" perimetries have recently been evaluated by several clinical studies which showed their ability to identify the earliest glaucoma changes; the most promising of these techniques are short-wavelength automated perimetry (SWAP) and frequency-doubling technology perimetry (FDT). The applicability of these techniques is still limited by a number of factors: the limited economic resources allocated to perimetry; the paucity of well-conducted, prospective longitudinal studies showing the superiority of SWAP and FDT over SAP; and the lack of a consensus on the criteria to define test abnormality with these techniques. The aim of this article is to review the rationale, the limits, and the potentiality of SWAP and FDT for glaucoma management and to summarize the tasks required to improve the clinical usefulness of these two instruments in the future.
Fogagnolo
Paolo
P
G.B. Bietti Foundation-Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy. fogagnolopaolo@googlemail.com
Rossetti
Luca
L
Ranno
Stefano
S
Ferreras
Antonio
A
Orzalesi
Nicola
N
D018450:Disease Progression; D005901:Glaucoma / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D012165:Retinal Ganglion Cells / Q000145:classification / Q000473:pathology / Q000502:physiology; D012984:Software; D058609:Visual Field Tests / Q000295:instrumentation / Q000379:methods; D014794:Visual Fields / Q000502:physiology